Julia Wendler
Klinikum Stuttgart(DE)
Publications by Year
Research Areas
CNS Lymphoma Diagnosis and Treatment, Glioma Diagnosis and Treatment, Lymphoma Diagnosis and Treatment, Thyroid Cancer Diagnosis and Treatment, Health Systems, Economic Evaluations, Quality of Life
Most-Cited Works
- → Clinical presentation, treatment and outcome of anaplastic thyroid carcinoma: results of a multicenter study in Germany(2016)122 cited
- → Objective Response and Prolonged Disease Control of Advanced Adrenocortical Carcinoma with Cabozantinib(2020)58 cited
- → High-dose chemotherapy and autologous stem cell transplant in elderly patients with primary CNS lymphoma: a pilot study(2020)52 cited
- → Effects on Survival of Non-Myeloablative Chemoimmunotherapy Compared to High-Dose Chemotherapy Followed By Autologous Stem Cell Transplantation (HDC-ASCT) As Consolidation Therapy in Patients with Primary CNS Lymphoma - Results of an International Randomized Phase III Trial (MATRix/IELSG43)(2022)43 cited
- → High-dose chemotherapy and autologous haematopoietic stem-cell transplantation in older, fit patients with primary diffuse large B-cell CNS lymphoma (MARTA): a single-arm, phase 2 trial(2024)35 cited
- → Somatostatin Receptor Expression in the Thyroid Demonstrated with 111In-Octreotide Scintigraphy(1995)22 cited
- → Bone Metastases in Medullary Thyroid Carcinoma: High Morbidity and Poor Prognosis Associated With Osteolytic Morphology(2020)21 cited
- → High-Dose Chemotherapy and Autologous Stem Cell Transplant in Elderly and Fit Primary CNS Lymphoma Patients - a Multicenter Study By the Cooperative PCNSL Study Group (MARTA study)(2022)12 cited
- → Optimizing MATRix as remission induction in PCNSL: de-escalated induction treatment in newly diagnosed primary CNS lymphoma(2022)11 cited
- → Age-adjusted high-dose chemotherapy followed by autologous stem cell transplantation or conventional chemotherapy with R-MP as first-line treatment in elderly primary CNS lymphoma patients – the randomized phase III PRIMA-CNS trial(2023)9 cited